DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Serri O, Li L, Mamputu JC, Beauchamp MC, Maingrette F, Renier G.
The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy.
Clin Endocrinol (Oxf) 2006; 64: 366-370
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.